Pricing Log in Create free account

Cabaletta Bio, Inc. (CABA) vs Palisade Bio, Inc. (PALI)

Cabaletta Bio, Inc. and Palisade Bio, Inc. are both Biotechnology companies. Cabaletta Bio, Inc. and Palisade Bio, Inc. are of similar size ($268.4M and $262.8M). Cabaletta Bio, Inc. has negative trailing earnings, so its P/E is not meaningful; Palisade Bio, Inc. trades at 2.2×. Cabaletta Bio, Inc. has the higher net margin (0.00% vs −4,230.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Palisade Bio, Inc. leads on 7 and Cabaletta Bio, Inc. on 5.

Valuation

Metric CABA PALI Biotechnology median
P/E n/m 2.18 8.50
P/S n/m 394.77 9.71
P/B 1.01 2.45 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.07 n/m 0.64
EV/Sales n/m 229.61 9.21
Earnings yield (111.35%) 45.93% (33.15%)
Free cash flow yield (72.80%) (6.11%) (25.50%)

Profitability

Metric CABA PALI Biotechnology median
Gross margin 0.00% 95.63% 65.16%
Operating margin 0.00% (4,681.99%) 0.00%
Net margin 0.00% (4,230.60%) 0.00%
Free cash flow margin 0.00% (2,409.27%) 0.00%
Return on equity (93.20%) (51.37%) (56.36%)
Return on assets (75.36%) (47.68%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CABA PALI Biotechnology median
Revenue growth (TTM) — 5,492.59% 6.02%
EPS growth (last fiscal year) 10.26% 97.06% 30.26%
Revenue growth, 5-year CAGR — 72.86% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CABA PALI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.79 24.26 4.72
Net debt to EBITDA 0.84 7.37 0.96

Dividend

Metric CABA PALI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CABA PALI Biotechnology median
Market cap 262.79m 268.38m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack